Associations between insulin-like growth factors and their binding proteins and other prognostic indicators in breast cancer
1996

Insulin-like Growth Factors and Breast Cancer

Sample size: 200 publication Evidence: moderate

Author Information

Author(s): H Yu, MA Levesque, MJ Khosravi, A Papanastasiou-Diamandi, GM Clark, EP Diamandis

Primary Institution: Mount Sinai Hospital, University of Toronto, and University of Texas Health Science Center at San Antonio

Hypothesis

Are insulin-like growth factors and their binding proteins associated with prognostic indicators in breast cancer?

Conclusion

High levels of IGF-II and IGFBP-3 are associated with unfavorable prognostic markers in breast cancer.

Supporting Evidence

  • IGF-II was positively correlated with IGFBP-3.
  • IGFBP-3 was positively associated with S-phase fraction.
  • Both IGF-II and IGFBP-3 were inversely associated with the estrogen receptor.

Takeaway

This study looked at proteins related to growth in breast cancer and found that some of them are linked to worse outcomes.

Methodology

Measured levels of IGF-I, IGF-II, IGFBP-1, IGFBP-3, and PSA in tumor tissue cytosols from 200 women with primary breast cancer.

Limitations

Clinical and follow-up information of the patients was not available.

Participant Demographics

Women with primary breast cancer.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication